2010Zhongguo linchuang yixueRequires access

Study of the Efficacy of Raberprazole Combined with Levofloxacin and Furazolidon in the Treatment of Helicobacter Intection

Guanghua Tang

Open publisher page 0 citations

Abstract

Objective:The aim of this study was to test the efficacy of Raberprazole combines Levofloxacin and Furazolidone for the treatment for Helicobacter pylori infection.Methods: Eighty-six H.pylori-positive patients(contain chronic gastritic and peptic ulcer) were randomized divided into therapy group and control group: Rabeprazole 10 mg bid +Levofloxacin 0.2g bid(therapy group)/ Amoxicillin 1.0g bid(control group)+Furazolidone 0.1g bid(therapy group)/Metronidizone 0.4g bid(control group) for 1 week.H.pylori was retested four weeks later.Results: The eradication rates of two regimen were: therapy group was 84.8%;control group was 75.0%.The eradication rates of H.pylori of the two groups were significant different(P0.05).Conclusions: Raberprazole+levofloxacin+furazolidone triple therapy for H.Pylori infection is effective、cheap and smaller side effect,it is worthy to be extended as one of the threatments for Helicobacter pylori infection.

About this research paper

What this paper is about

Objective:The aim of this study was to test the efficacy of Raberprazole combines Levofloxacin and Furazolidone for the treatment for Helicobacter pylori infection.Methods: Eighty-six H.pylori-positive patients(contain chronic gastritic and peptic ulcer) were randomized divided into therapy group and control group: Rabeprazole 10 mg bid +Levofloxacin 0.2g bid(therapy group)/ Amoxicillin 1.0g bid(control group)+Furazolidone 0.1g bid(therapy group)/Metronidizone 0.4g bid(control group) for 1 week.H.pylori was retested four weeks later.Results: The eradication rates of two regimen were: therapy group was 84.8%;control group was 75.0%.The eradication rates of H.pylori of the two groups were significant different(P0.05).Conclusions: Raberprazole+levofloxacin+furazolidone triple therapy for H.Pylori infection is effective、cheap and smaller side effect,it is worthy to be extended as one of the threatments for Helicobacter pylori infection.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:The aim of this study was to test the efficacy of Raberprazole combines Levofloxacin and Furazolidone for the treatment for Helicobacter pylori infection.Methods: Eighty-six H.pylori-positive patients(contain chronic gastritic and peptic ulcer) were randomized divided into therapy group and control group: Rabeprazole 10 mg bid +Levofloxacin 0.2g bid(therapy group)/ Amoxicillin 1.0g bid(control group)+Furazolidone 0.1g bid(therapy group)/Metronidizone 0.4g bid(control group) for 1 week.H.pylori was retested four weeks later.Results: The eradication rates of two regimen were: therapy group was 84.8%;control group was 75.0%.The eradication rates of H.pylori of the two groups were significant different(P0.05).Conclusions: Raberprazole+levofloxacin+furazolidone triple therapy for H.Pylori infection is effective、cheap and smaller side effect,it is worthy to be extended as one of the threatments for Helicobacter pylori infection.

Key concepts: Furazolidone, Levofloxacin, Rabeprazole, Medicine, Helicobacter pylori, Amoxicillin, Gastroenterology, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Study of the Efficacy of Raberprazole Combined with Levofloxacin and Furazolidon in the Treatment of Helicobacter Intection — Research Paper | ScholarLens